SCHEDULE: Rosalind Group Discloses 9.9% Stake in PolyPid

Rosalind Advisors and affiliated entities report a 9.9% beneficial ownership stake in PolyPid Ltd., including common shares and warrants.

Summary

• Rosalind Advisors, Inc., Rosalind Master Fund L.P., Steven Salamon, and Gilad Aharon collectively reported beneficial ownership of 5,762,349 shares of PolyPid Ltd. Common Shares.
• This aggregate amount represents 9.9% of PolyPid Ltd.'s outstanding common stock.
• The ownership comprises 975,462 shares of Common Stock and 4,786,887 shares issuable upon the exercise of warrants.
• The percentage is calculated based on 15,897,201 Ordinary shares outstanding as of July 27, 2025, as per PolyPid's F-3 Filing of July 29, 2025.
• A blocker provision in the warrants prevents the holders from exercising them to the extent that such exercise would result in beneficial ownership exceeding 9.99% of the Common Stock.
• Due to these blockers, the Reporting Persons were not able to exercise any of the warrants as of the filing event date.

Sentiment

Score: 5

Explanation: The filing is a factual disclosure of beneficial ownership and does not contain information that would indicate a positive or negative sentiment regarding the issuer's performance or outlook.

Positives

• The disclosure of a significant 9.9% beneficial ownership stake by institutional investors like Rosalind Advisors and its affiliates may signal confidence or strong interest in PolyPid Ltd.'s prospects.

Negatives

• The presence of a 'blocker provision' means that the reporting persons cannot currently exercise 4,786,887 shares issuable upon warrants if it would push their beneficial ownership above 9.99%, limiting their immediate ability to increase their stake through these instruments.

Risks

• The filing does not detail specific risks related to PolyPid Ltd.'s operations or financial health; it focuses solely on beneficial ownership disclosure.

Future Outlook

This filing is a beneficial ownership report and does not contain forward-looking statements or guidance from PolyPid Ltd. or the reporting persons regarding the issuer's future performance.

Industry Context

This filing is a standard disclosure of beneficial ownership by an institutional investor group in a publicly traded company. It does not provide broader industry trends or competitive analysis.

Stakeholder Impact

• Shareholders: The disclosure of a significant institutional stake may influence investor perception and potentially the stock's trading activity.

Key Dates

Keywords

PolyPid Ltd., Rosalind Advisors, Beneficial Ownership, Schedule 13G, Common Shares, Warrants, Institutional Investment, SEC Filing